U.S. federal government (CMS)
Customer Exposure
~83% of premiums and services revenue comes from federal government contracts; 14% tied to CMS Medicare Advantage in Florida.
Relevance 98·Dependency 95·Confidence 99
Source evidence
“We derived approximately 83% of our total premiums and services revenue from contracts with the federal government in 2025, including 14% related to our federal government contracts with the Centers for Medicare and Medicaid Services, or CMS”
U.S. federal government (CMS)
Customer Exposure
83% of 2025 premiums and services revenue derives from federal government contracts; 14% from CMS individual MA contracts in Florida alone.
Relevance 98·Dependency 83·Confidence 99
Source evidence
“During 2025, 83% of our total premiums and services revenue were derived from contracts with the federal government”
Medicare Advantage regulation
Regulatory Exposure
Changes to Medicare Advantage premiums/payment rates directly affect Humana's core revenue and medical cost structure.
Relevance 95·Dependency 90·Confidence 95
Source evidence
“adjustments to Medicare Advantage premiums”
Federal/state Medicare and Medicaid policy
Revenue Exposure
Government policies shape premiums/revenues, member eligibility and enrollment, services, and administrative and health care costs across Medicare Advantage, PDP, military services, and Medicaid programs.
Relevance 95·Dependency 90·Confidence 97
Source evidence
“These governmental policies and decisions, which we cannot predict with certainty, directly shape the premiums or other revenues to us under the programs”
CMS Star Ratings
Regulatory Exposure
2025 Star Ratings decline directly threatens 2026 CMS quality bonus payments and could significantly adversely affect revenues, operating results, and cash flows.
Relevance 95·Dependency 85·Confidence 98
Source evidence
“the decline in our Star Ratings will negatively impact our 2026 quality bonus payments from CMS and may also significantly adversely affect our revenues, operating results, and cash flows”
Medicare Advantage
Revenue Exposure
Individual Medicare Advantage is the largest product family at $90,403M (70.3% of consolidated premiums and services revenue) with ~5.2 million members.
Relevance 95·Dependency 82·Confidence 97
Source evidence
“Individual Medicare Advantage$90,403 70.3 %”
United States
Revenue Exposure
Medicare product family accounts for 82.6% of consolidated premiums and services revenue, entirely U.S. federal program revenue dependent on CMS payment policy.
Relevance 95·Dependency 80·Confidence 95
Source evidence
“Total Medicare106,261 82.6 %”
CMS Medicare program
Regulatory Exposure
Medicare risk adjustment provisions related to CMS contracts are a critical accounting estimate, exposing results to regulatory changes.
Relevance 92·Dependency 85·Confidence 94
Source evidence
“the impact of risk adjustment provisions related to our Medicare contracts”
Health Care Reform Law (ACA)
Regulatory Exposure
ACA-era reforms impose benefit ratio rebates, guaranteed issuance, and plan design requirements on Humana's insurance products.
Relevance 90·Dependency 85·Confidence 95
Source evidence
“mandated coverage requirements, mandated benefits and guarantee issuance associated with commercial medical insurance, rebates to policyholders based on minimum benefit ratios”
2025 Star Ratings lawsuit
Legal Exposure
Litigation against CMS over 2025 Star Ratings creates uncertain outcome; losing would cement the negative impact on 2026 quality bonus payments and membership/profit margins.
Relevance 90·Dependency 80·Confidence 95
Source evidence
“our plans may not be eligible for full level quality bonuses or may not match the performance of our competitors, each of which could materially and adversely affect the benefits such plans can offer, reduce membership and/or reduce profit margins”
Medical cost inflation
Revenue Exposure
Medical cost inflation is a named driver that can cause actual health care costs to exceed premiums, which are fixed for one-year periods and cannot be repriced mid-year.
Relevance 90·Dependency 80·Confidence 95
Source evidence
“premiums in the health care business are fixed for one-year periods. Accordingly, costs we incur in excess of our benefit cost projections generally are not recovered in the contract year through higher premiums”
CMS risk-adjustment model (BBA/BIPA)
Regulatory Exposure
MA premium payments are risk-adjusted by CMS based on provider-submitted diagnosis codes; coding accuracy directly affects revenue.
Relevance 90·Dependency 75·Confidence 92
Source evidence
“Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines.”
False Claims Act / Anti-Kickback Statute / Stark Law
Legal Exposure
Fraud and abuse law violations could lead to exclusion from Medicare and Medicaid programs, the payer base for Humana's core business.
Relevance 85·Dependency 80·Confidence 95
Source evidence
“exclusion from participating in the Medicare and Medicaid programs or other government healthcare programs”
Prescription drugs (including specialty)
Cost Driver
Increased use or cost of prescription drugs, including specialty drugs, and changes in pharmacy volume rebates from drug manufacturers are disclosed drivers of medical cost overruns.
Relevance 85·Dependency 75·Confidence 92
Source evidence
“increased use or cost of prescription drugs, including specialty prescription drugs;”
Florida (geographic concentration)
Revenue Exposure
Florida individual MA contracts with CMS represent ~$17.8 billion premiums, ~20% of individual MA premiums and 14% of consolidated premiums and services revenue.
Relevance 85·Dependency 70·Confidence 97
Source evidence
“Florida contracts accounted for premiums revenue of approximately $17.8 billion, which represented approximately 20% of our individual Medicare Advantage premiums revenue, or 14% of our consolidated premiums and services revenue”
Medical benefits expense is the dominant cost; benefits payable estimation is a critical estimate.
Relevance 82·Dependency 70·Confidence 92
Source evidence
“The areas involving the most significant use of estimates are the estimation of benefits payable”
Inflation Reduction Act of 2022
Regulatory Exposure
The Inflation Reduction Act changed the Part D prescription drug benefit design, relevant to Humana's Part D and prescription drug benefit businesses.
Relevance 80·Dependency 75·Confidence 90
Source evidence
“changes to the Part D prescription drug benefit design (and uncertainty arising from the implementation of these changes) may have a material adverse effect on our results of operations”
AI/ML information systems
Technology Dependency
Pricing, service, product innovation, claims payment efficiency, and financial reporting depend significantly on information systems, requiring ongoing significant investment including AI/ML (including generative AI) systems.
Relevance 80·Dependency 75·Confidence 90
Source evidence
“Our ability to adequately price our products and services, provide effective and efficient service to our customers, develop new and innovative products and services... depends significantly on the performance of, and integrity of the data, in our information systems”
HIPAA/HITECH Act
Regulatory Exposure
HIPAA/HITECH govern use of individually identifiable health data, requiring systems enhancements, training, and exposing Humana to penalties including for business associates.
Relevance 80·Dependency 75·Confidence 95
Source evidence
“Compliance with HIPAA and other privacy regulations requires significant systems enhancements, training and administrative effort. HIPAA can also expose us to additional liability for violations by our business associates”
Regulatory and competitive pressures
Demand Driver
Sustained macroeconomic, regulatory and competitive pressures drove the transformation program and impairments.
Relevance 78·Dependency 65·Confidence 90
Source evidence
“in response to sustained macroeconomic, regulatory and competitive pressures impacting the industry”
State insurance regulation
Regulatory Exposure
State holding company regulations require prior approval for dividends, asset transactions, and intercompany agreements, affecting capital flexibility.
Relevance 75·Dependency 70·Confidence 90
Source evidence
“These regulations generally require, among other things, prior approval and/or notice of new products, rates, benefit changes, and certain material transactions, including dividend payments”
14% of premiums/services revenue tied to CMS contracts for individual Medicare Advantage members in Florida.
Relevance 72·Dependency 68·Confidence 92
Source evidence
“including 14% related to our federal government contracts with the Centers for Medicare and Medicaid Services, or CMS, to provide health insurance coverage for individual Medicare Advantage members in Florida”
State-based contracts (Medicaid, dual eligible, LTSS)
Revenue Exposure
State-based contracts and other premiums of $14,477M (11.2% of consolidated) from Medicaid, dual eligible demonstration, and LTSS contracts with various states.
Relevance 72·Dependency 55·Confidence 93
Source evidence
“contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts”
Corporate practice of medicine statutes
Legal Exposure
Humana's health services delivery model relies on management agreements with physician-owned groups to comply with state corporate practice of medicine laws.
Relevance 70·Dependency 65·Confidence 90
Source evidence
“business corporations generally may not exercise control over the medical decisions of physicians”
Medicare Part D (PDP)
Revenue Exposure
Medicare stand-alone PDP premiums of $6,844M (5.3% of consolidated), plus Part D embedded in most MA plans.
Relevance 70·Dependency 60·Confidence 90
Source evidence
“Medicare stand-alone PDP6,844 5.3 %”
Humana Inc.
Legal Exposure
Commitments and contingencies noted in balance sheet (Note 17), signaling potential legal/contingent liabilities.
Relevance 70·Dependency 60·Confidence 85
Source evidence
“Commitments and contingencies (Note 17)”
Catastrophes/climate change
Revenue Exposure
Catastrophes such as terrorism, public health emergencies, epidemics/pandemics, or natural disasters (hurricanes, earthquakes), potentially intensified by global climate change, may cause costs to exceed estimates.
Relevance 70·Dependency 55·Confidence 88
Source evidence
“catastrophes, including acts of terrorism, public health emergencies, epidemics or pandemics (such as COVID-19), or natural disasters (such as hurricanes and earthquakes) which could occur more frequently or with more intense effects as a result of the impact of global climate change”
Workforce optimization / labor costs
Cost Driver
Severance and workforce optimization charges dominate value creation initiative charges ($329M in 2025), reflecting cost restructuring aimed at funding growth.
Relevance 68·Dependency 50·Confidence 90
Source evidence
“The value creation initiative charges primarily relate to $329 million, $25 million and $199 million in severance and other employee related charges in connection with workforce optimization”
Workforce optimization severance charges ($329M in 2025) are a material component of restructuring charges.
Relevance 65·Dependency 55·Confidence 88
Source evidence
“$329 million, $25 million and $199 million in severance and other employee related charges in connection with workforce optimization in 2025, 2024 and 2023, respectively”
Technology footprint
Technology Dependency
Transformation program includes re-aligning the technology footprint.
Relevance 60·Dependency 55·Confidence 85
Source evidence
“designed to re-align our cost structure, operating model and technology footprint with evolving market conditions”